Notably, the comparable frequency of KRAS G12C mutations in the “large cell carcinoma” histology group and lung adenocarcinoma supports the hypothesis that a substantial portion of large cell carcinomas are undifferentiated TTF1-negative adenocarcinomas. The gene discussed is KRAS; the disease is large cell carcinoma.